|
FY2019
12 months to Mar 31, 2019
|
FY2018
12 months to Mar 31, 2018
|
FY2017
12 months to Mar 31, 2017
|
FY2016
12 months to Mar 31, 2016
|
FY2015
12 months to Mar 31, 2015
|
|
|---|---|---|---|---|---|
| REVENUE, NET | |||||
| Products, net | |||||
| Products | |||||
| Services | |||||
| Total revenues, net | |||||
| COST OF REVENUE | |||||
| Products | |||||
| Services | |||||
| Total costs of revenue | |||||
| GROSS MARGIN | |||||
| EXPENSES | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Amortization | |||||
| Reverse merger costs | |||||
| Depreciation and Amortization | |||||
| Impairment of asset | |||||
| TOTAL OPERATING EXPENSES | |||||
| OPERATING LOSS | |||||
| Other Income (Expense) | |||||
| Change in fair value of equity investments | |||||
| Dividend received from equity investment | |||||
| Interest Expense | |||||
| Total other (expense), net | |||||
| NET LOSS | |||||
| Less: Net loss (income) attributable to non controlling interest | |||||
| NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP. | |||||
| LOSS PER COMMON SHARE | |||||
| WEIGHTED AVERAGE SHARES OUTSTANDING | |||||
| Basic and diluted |
Loading...